产品名称 | NebuSelect™ Recombinant Biotinylated Human B7-H6, Avi-His-tag |
---|---|
目录号 | NBL-243020 |
别名 | B7-H6; B7H6; B7-H6; DKFZp686I21167; DKFZp686O24166; NCR3LG1; B7 Homolog 6 |
外观 | see COA |
分子量 | |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | Q68D85 |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-243020-100ug | 100ug | Inquire | Inquire | |
NBL-243020-1mg | 1mg | Inquire | Inquire | |
NBL-243020-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Biotinylated Human B7-H6, Avi-His-tag
Catalog#:
NBL-243020
Description:
NebuSelect™ Recombinant Biotinylated Human B7-H6, Avi-His-tag(Cat#NBL-243020) is expressed in HEK293 with His tag and Avi tag at the C-Terminus.It contains Asp25-Ser262.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 29.6 kDa. Due to glycosylation, the protein migrates to 48-65 kDa based on Bis-Tris PAGE result.
Target Name:
B7-H6; B7H6; B7-H6; DKFZp686I21167; DKFZp686O24166; NCR3LG1; B7 Homolog 6
Target Information:
B7-H6 is a glycosylated member of the B7 family of immune co‑stimulatory proteins. which is a ligand for the NK cell activating receptor NKp30, was targeted to create a CAR that targets multiple tumor types. B7H6 is expressed on various primary human tumors, including leukemia, lymphoma and gastrointestinal stromal tumors, but it is not constitutively expressed on normal tissues.
Amino Acid Sequence:
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.